Countdown to a Silver Jubilee for Heart, Lung and Circulation Journal in 2016 - Looking Back in Order to Move Forward

Heart Lung and Circulation

Volumn 24, Issue 12, 2015, Pages 1137-1140

  Denniss, A Robert ^a,b,c   Gregory, Ann T ^a  

^a University of Sydney ^*  (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; AORTA COARCTATION; AORTA DISSECTION; AORTA SURGERY; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; ATRIAL FIBRILLATION; AUSTRALIAN ABORIGINE; BARE METAL STENT; BIORESORBABLE SCAFFOLD; BRAIN EMBOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS SURGERY; DIAGNOSTIC PROCEDURE; DRUG ELUTING STENT; EDITORIAL; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; EXERCISE TEST; FRACTIONAL FLOW RESERVE; GRAFT SURVIVAL; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEART ATRIUM SEPTUM DEFECT; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART PRESERVATION; HEART REHABILITATION; HEART TRANSPLANTATION; HEART VALVE SURGERY; HEART VENTRICLE SEPTUM DEFECT; HOSPITALIZATION; HUMAN; IMPLANTABLE CLIP; INDIVIDUALIZATION; INTERMETHOD COMPARISON; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RESEARCH; MINIMALLY INVASIVE SURGERY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MORTALITY; OPEN HEART SURGERY; PATENT FORAMEN OVALE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLISHING; RISK MANAGEMENT; SECONDARY PREVENTION; SEDATION; SOCIAL STATUS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STARR EDWARDS VALVE PROSTHESIS; SURGICAL TECHNIQUE; TRANSCATHETER AORTIC VALVE IMPLANTATION; ANIMAL; CIRCULATION; HEART; HISTORY; LUNG; PUBLICATION;

ANIMALS; ANNIVERSARIES AND SPECIAL EVENTS; BLOOD CIRCULATION; HEART; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LUNG; PERIODICALS AS TOPIC;

EID: 84947259843     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/S1443-9506(15)01460-2     Document Type: Editorial

References (69)

1. Burke J. Countdown (Episode 9). Connections 1979. izquotes.com/quote/215056 (accessed 19 October 2105).
2. Denniss A.R. Changes in management of acute myocardial infarction over the last 110 years. Heart Lung Circ 2013, 22:883-884.
3. Weintraub W.S., Daniels S.R., Burke L.A., Franklin B.A., Goff D.C., Hayman L.L., et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation 2011, 124:967-990.
4. Clark A., Hartling L., Vandermeer B., Lissel S., McAlister F. Secondary prevention programs for coronary heart disease: a meta-regression showing the merits of shorter, generalist, primary care-based interventions. Eur J Cardiovasc Prev Rehabil 2007, 14:538-546.
5. Redfern J., Chow C. Stengthening preventive Cardiology. Heart Lung Circ 2015, 24:427-429.
6. Vickery A., Bell D., Garton-Smith J., Kirk A.B., Pang J., Watts G.F. Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services. Heart Lung Circ 2015, 24:1158-1164.
7. Ong K.S., Carter R., Vos T., Kelaher M., Anderson I. Cost-effectiveness of interventions to prevent cardiovascular disease in Australia's Indigenous population. Heart Lung Circ 2014, 23:414-421.
8. Jennings G.L.R. A new guideline on treatment of hypertension in those with coronary artery disease. Scientific statement from the American Heart Association, American College of Cardiology and American Association of Hypertension about treatment of hypertension in patients with coronary artery disease. Heart Lung Circ 2015, 24:1037-1040.
9. Charlton F., Tooher J., Rye K., Hennessy A. Cardiovascular risk, lipids and pregnancy:preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circ 2014, 23:203-212.
10. Nestel P., Clifton P., Colquhoun D., Noakes M., Mori T.A., Sullivan D., et al. Indications for omega-3 long chain polyunsaturated fatty acid in the prevention and treatment of cardiovascular disease. Heart Lung Circ 2015, 24:769-779.
11. McLennan P.L., Pepe S. Weighing up fish and omega-3 PUFA advice with accurate, balanced scales: stringent controls and measure required for clinical trials. Heart Lung Circ 2015, 24:740-743.
12. Sullivan D.R., Watts S.J., Nicholls P., Barter P., Grenfell R., Chow C.K., et al. Clinical guidelines on hyperlipidaemia: recent developments, future challenges and the need for an Australian review. Heart Lung Circ 2015, 24:495-502.
13. Noaman S., Ibrahim J.E., Grenfell R. Prescribing statins for cardiovascular disease prevention in the old: an absence of evidence and an absence of guidelines. Heart Lung Circ 2014, 23:619-624.
14. Wang J., Wu G., Wang Z., Dai X., Li X. Long-term clinical outcomes of statin use for chronic heart failure: a meta-analysis of 15 prospective studies. Heart Lung Circ 2014, 23:105-113.
15. Woodruffe S., Neubeck L., Clark R.A., Gray K., Ferry C., Finan J., et al. Australian Cardiovascular Health and Rehabilitation Association (ACRA) core components of cardiovascular disease secondary prevention and cardiac rehabilitation 2014. Heart Lung Circ 2015, 24:430-441.
16. Vohra J., Rajagopalan S. Update on the diagnosis and management of Brugada syndrome. Heart Lung Circ 2015, 24:1141-1148.
17. Ward M. Proposed recommendations for myocardial revascularisation. Heart Lung Circ 2015, 24:635-643.
18. Edelman J.J., Tatoulis J., Hayward P.A., Smith J.A., Costa R.J., Vallely M.P., et al. ANZSCTS response to the discussion paper: Proposed recommendations for myocardial revascularisation. Heat Lung Circ 2015, 24:646-648.
19. Colquhoun D., Freedman B., Cross D., Fitzgerald B., Forge B., Hare D.L., et al. Clinical exercise stress testing in adults (2014). Heart Lung Circ 2015, 24:831-837.
20. Thomas S.P., Thakkar J., Kovoor P., Thiagalingam A., Ross D.L., MacIsaac A., et al. CSANZ Position Statement on sedation for cardiovascular procedures (2014). Heart Lung Circ 2015, 24:1041-1048.
21. Walters D.L., Webster M., Pasupati S., Walton A., Muller D., Stewart J., et al. Position Statement for the operator and institutional requirements for a transcatheter aortic valve implantation (TAVI) program. Heart Lung Circ 2015, 24:219-223.
22. Brown A., O'Shea R.L., Mott K., McBride K.F., Lawson T., Jennings G.L.R. A strategy for translating evidence into policy and practice to close the gap - developing essential service standards for Aboriginal and Torres Strait Islander Cardiovascular Care. Heart Lung Circ 2015, 24:119-125.
23. Brown A., O'Shea R.L., Mott K., McBride K.F., Lawson T., Jennings G.L.R. Essential service standards for for equitable national cardiovascular care for Aboriginal and Torres Strait Islander people. Heart Lung Circ 2015, 24:126-141.
24. Kritharides L., Lowe H.C. Extracting the ESSENCE - cardiovascular health for Aboriginal and Torres Strait Islander Australians. Heart Lung Circ 2015, 24:107-109.
25. Farshid A., Allada C., Chandrasekhar J., Marley P., McGill D., O'Connor S., et al. Shorter ischaemic time and improved survival with pre-hospital STEMI diagnosis and direct transfer for primary PCI. Heart Lung Circ 2014, 23:234-240.
26. Savage M., Poon K.C., Johnston E.M., Raffel O.C., Incani A., Bryant J., et al. Prehospital ambulance notification and initiation of treatment of ST elevation myocardial infarction is associated with significant reduction in door-to-balloon time for primary PCI. Heart Lung Circ 2014, 23:435-443.
27. Cullen L., Greenslade J., Than M., Tate J., Ungerer J.P.J., Pretorius C., et al. Performance of risk stratification for acute coronary syndrome with two-hour sensitive troponin assay results. Heart Lung Circ 2014, 23:428-434.
28. Lin A., Oh T., Alawami M., Webster M., El-Jack S., Scott D., et al. A review of a regional primary percutaneous coronary intervention service, with a focus on door to reperfusion times: the 2012 Auckland/Northland experience. Heart Lung Circ 2015, 24:11-20.
29. Siebert U., Arvandi M., Gothe R.M., Bornschein B., Eccleston D., Walters D.L., et al. Improving the quality of percutaneous revascularization in patients with multivessel disease in Australia: cost-effectiveness, public health implications, and budget impact of FFR_guided PCI. Heart Lung Circ 2014, 23:527-533.
30. Murphy J.C., Hansen P.R., Bhindi R., Figtree G.A., Nelson G.I.C., Ward M. Cost benefit for assessment of intermediate coronary stenosis with fractional flow reserve in public and private sectors in Australia. Heart Lung Circ 2014, 23:807-810.
31. Sarathy K., Nagaraja V., Kapur A., Szirt R., Raval J., Eslick G., et al. Target vessel versus multivessel revascularisation in ST-elevation myocardial infarction: a meta-analysis of randomised trials. Heart Lung Circ 2015, 24:327-334.
32. Sun L., Zhang J. Biodegradable polymer drug-eluting stents versus durable polymer everolimus eluting stents for patients undergoing PCI; a meta-analysis. Heart Lung Circ 2014, 23:496-502.
33. Robaei D., Back L.M., Ooi S.M., Pintney M., Jepson N. Everolimus-eluting bioabsorbable vascular scaffold implantation in real world and complex coronary disease: procedural and 30 day outcomes at two Australian centres. Heart Lung Circ 2015, 24:854-859.
34. Close G., Newton P.J., Fung S.C., Denniss A.R., Halcomb E.J., Kovoor P., et al. Socioeconomic status and heart failure in Sydney. Heart Lung Circ 2014, 23:320-324.
35. Betihavas V., Frost S.A., Newton P.J., MacDonald P., Stewart S., Carrington M., et al. Absolute risk prediction model to determine unplanned cardiovascular readmissions for adults with chronic heart failure. Heart Lung Circ 2015, 24:1068-1073.
36. Liu W., Luo Q., Zhao Q., Xi Q., Zhao Z. Differences in exercise capacity in patients with chronic left heart failure and chronic right heart failure. Heart Lung Circ 2014, 23:1036-1040.
37. Andrea R., Lopez-Giraldo A., Falces C., Sobradillo P., Sanchis L., Gistau C., et al. Lung function abnormalities are highly frequent in patients with heart failure and preserved ejection fraction. Heart Lung Circ 2014, 23:273-279.
38. Iyngkaran P., Harris M., Ilton M., Kangaharan N., Battersby M., Stewart S., et al. Implementing guideline based heart failure in the Northern Territory. Heart Lung Circ 2014, 23:391-406.
39. Ma P., Zhang Z., Song T., Yang Y., Zhao G.M.J., Wang C., et al. Combining ECMO with IABP for treatment of critically ill adult heart failure patients. Heart Lung Circ 2014, 23:363-368.
40. Seco M., Martinez G., Bannon P., Cartwright B.L., Adams M., Ng M., et al. Transapical aortic valve implantation- an Australian experience. Heart Lung Circ 2014, 23:462-468.
41. Phan K., Wong S., Phan S., Ha H., Qian P., Yan T.D. Transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valve stenosis - systematic review and meta-analysis. Heart Lung Circ 2015, 24:649-659.
42. Raval J., Nagaraja V., Eslick D., Denniss A.R. Transcatheter valve-in-valve implantation: a systematic review of the literature. Heart Lung Circ 2014, 23:1020-1028.
43. Muller D.W.M., Jansz P. A clip in time - selecting interventions for severe mitral valve regurgitation. Heart Lung Circ 2014, 23:493-495.
44. Bhamra-Ariza P., Muller D.W.M. The MitraClip experience and future percutaneous mitral valve therapies. Heart Lung Circ 2014, 23:1009-1019.
45. Edelman J.J.B., Dias P., Passage J., Yamen E. Percutaneous mitral valve repair in a high-risk Australian series. Heart Lung Circ 2014, 23:520-526.
46. Pandit A., Arval M.R., Pandit A.A., Jalota L., Kantharaipur S., Hakim F.A., et al. Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke. Heart Lung Circ 2014, 23:303-308.
47. Romanelli G., Harper R.W., Mottram P.M. Transcatheter closure of secundum atrial septal defects: results in patients with large and extreme defects. Heart Lung Circ 2014, 23:127-131.
48. Xu X., Bai Y.B., Chen X., Liu S., Zhao X., Qin Y. Simultaneous transcatheter treatment of perimembranous ventricular septal defect and other congenital cardiopathies. Heart Lung Circ 2014, 23:1169-1174.
49. Gan C.H., Bhat A., Davis L., Denniss A.R. Percutaneous transcatheter left atrial appendage closure devices: role in the long-term management of atrial fibrillation. Heart Lung Circ 2014, 23:407-413.
50. Vizzardi E., Trichadi E., Bonadei I., Sciatti E., Salghetti E., Salghetti F., Raddino R., et al. Elastic properties in patients with X syndrome. Heart Lung Circ 2014, 23:114-118.
51. Huang F.Q., Tan J.L. Pattern of aortic dilatation in different bicuspid aortic valve phenotypes and its association with aortic valvular dysfunction and elasticity. Heart Lung Circ 2014, 23:32-38.
52. Tong F., Li Z., Chong M., Zhu Y., Su J., Liu Y. The follow-up of surgical results of coarctation of the aorta procedures in a cohort of Chinese children from a single institution. Heart Lung Circ 2014, 23:339-346.
53. Zhang J., Jiang Y., Gao C., Feng J., Wang A. Risk factors for hospital death in patients with acute aortic dissection. Heart Lung Circ 2015, 24:348-353.
54. Singh S., Hakim F.A., Sharma A., Roy R.R., Panse P.M., Chandrasekaran K., et al. Hypoplasia, pseudocoarctation and coarctation of the aorta - a systematic review. Heart Lung Circ 2015, 24:110-118.
55. Wang T.K.M., Li A.Y., Ramanathan T., Stewart R.A.H., Gamble G., White H.D. Comparison of four risk scores for contemporary isolated coronary artery bypass grafting. Heart Lung Circ 2014, 23:469-474.
56. Paterson H.S., Thakkar J., Byth K., Denniss A.R. Saphenous vein to internal mammary artery end-to-end composite grafts for coronary artery bypass. Late follow-up. Heart Lung Circ 2015, 24:200-205.
57. Dai C., Zhang W., Lu Z., Zhu H., Xue S., Lian F. Comparison of the safety of right internal mammary versus radial artery for the second arterial conduit during coronary artery bypass grafting. Heart Lung Circ 2014, 23:1179-1186.
58. Ch'ng S.L., Cochrane A.D., Wolfe R., Reid C., Smith C.I., Smith J.A. Procedure specific cardiac surgical volume associated with patient outcome following valve surgery but not isolated CABG surgery. Heart Lung Circ 2015, 24:583-589.
59. Ho E., Mathur M.N., Brady P., Marshman D., Brereton R.J., Ross D.E., et al. Surgical aortic valve replacement in very elderly patients aged 80 years and over: evaluation of early clinical outcomes. Heart Lung Circ 2014, 23:242-248.
60. Wang T.K., Sathananthan J., Ramanathan T., Webster M., Ruygrok P. Isolated aortic valve replacement in octogenarians before and after the introduction of transcatheter aortic valve replacement. Heart Lung Circ 2014, 23:249-255.
61. Seco M., Edelman J.J., Forrest P., Ng M., Wilson M., Fraser J., et al. Geriatric cardiac surgery: chronology versus biology. Heart Lung Circ 2014, 794-801.
62. Lim J.Y., Deo S.V., Jung S.H., Altarabsheh S.E., Erwin P.J., Dillon J.D., et al. Does off-pump coronary artery bypass confer any advantage in patients with end-stage renal failure? A systematic review and meta-analysis. Heart Lung Circ 2015, 24:55-61.
63. Hill T.B.K., John G., Lainchbury J.G., Bridgman P.G. Frailty in Cardiology comparison of a quick clinical assessment against a validated frailty assessment. Heart Lung Circ 2015, 24:551-556.
64. Zhang Q., Zhou Z., Lin M., Wang H., Zhao J. Thoroscope assisted right vertical infra-axillary mini-incision for cardiac surgery. Heart Lung Circ 2015, 24:590-594.
65. Shannon j., Murphy M.J., Weightman W.M., Gibbs N.M., Edelman J.B., Passage J. Minimally invasive mitral valve surgery using single dose anterograde custodial cardioplegia. Heart Lung Circ 2014, 23:863-868.
66. Qiao Y., An G., Chen G., Zheng S., Ni L., Wang W., et al. Minimally invasive video assisted double valve replacement through right anterolateral minithoracotomy. Heart Lung Circ 2014, 23:847-851.
67. Ayub B., Guthier J., Wu J.K., Martinez M.W. Durability, reliability, viability; 48 year survival of a Starr-Edwards mitral valve. Heart Lung Circ 2014, 23:96-97.
68. Rosenfeldt, Ou R., Woodward J., Esmore D., Marasco S. Twelve hour reanimation of a human heart following donation after circulatory death. Heart Lung Circ 2014, 23:88-90.
69. Stamp N., Shah A., Vincent V., Wright B., Wood C., Pavey W., et al. Successful heart transplant after 10hours out of body time using the TransMedics organ care system. Heart Lung Circ 2015, 24:88-90.